72.11.Z - Research and experimental development on biotechnology
20.13.Z - Manufacture of other inorganic basic chemicals
20.14.Z - Manufacture of other organic basic chemicals
20.59.Z - Manufacture of other chemical products not elsewhere classified
32.50.Z - Manufacture of medical and dental instruments and supplies
46.46.Z - Wholesale of pharmaceutical goods
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
63.11.Z - Data processing, hosting and related activities
71.20.B - Other technical testing and analysis
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 4,8 | 30,6 | 1 | -96,9 |
Gross profit (loss) | -0,2 | -52,1 | -0,8 | 98,5 |
Net profit (loss) | -0,2 | -52,1 | -0,8 | 98,5 |
Liabilities and provisions for liabilities | 0 | 21,9 | -28 | -228 |
Income tax | 0 | 0 | 0 | 0 |
Equity capital | 4,8 | 8,7 | 28,9 | 231,5 |
Working assets | 4,8 | 30,6 | 1 | -96,9 |
Basic operational activity income | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -3,8 | -596,9 | -2,7 | 594,2 |
Equity capital to total assets | 100 | 28,5 | 3011,8 | 2983,3 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.